Cydan is an orphan drug accelerator that identifies and de-risks compounds with therapeutic and commercial potential. Their rigorous process generates data to support a development path and new company formation. Cydan’s experienced and globally networked team brings strong relationships with academia and patient advocacy, deep expertise in drug development, and a track record of successful product commercialization.
Type
Private
HQ
Lincoln, US
Founded
2012
Size (employees)
10 (est)+12%
Cydan was founded in 2012 and is headquartered in Lincoln, US
Report incorrect company information

Cydan Office Locations

Cydan has an office in Lincoln
Lincoln, US (HQ)
16 Conant Road
Show all (1)
Report incorrect company information

Cydan Financials and Metrics

Summary Metrics

Founding Date

2012

Total Funding

$60 m

Latest funding size

$34 m

Time since last funding

8 months ago

Investors

Cydan's latest funding round in October 2017 was reported to be $34 m. In total, Cydan has raised $60 m
Show all financial metrics
Report incorrect company information

Cydan Online and Social Media Presence

Embed Graph
Report incorrect company information